← All stories
Markets

KRM22 plc Executive Director Keith Todd Boosts Stake to 14.9% with 350,000 Shares Bought at 28p

1 source ·1 article ·1h ago AIM ImmunoTech

KRM22 plc (AIM: KRM), the London-based technology and software investment firm specializing in capital markets risk management, revealed that Executive Director Keith Todd acquired 350,000 ordinary shares on 20 August 2026 at 28 pence each.…

Covered by 1 outlet

All coverage · 1 article